Literature DB >> 11517009

Circulating leptin concentrations and ovarian function in polycystic ovary syndrome.

I R Pirwany1, R Fleming, N Sattar, I A Greer, A M Wallace.   

Abstract

OBJECTIVE: Polycystic ovary syndrome (PCOS) is characterized by ovarian dysfunction. Although the role of leptin in the control of reproduction is unclear, it may be involved in the control of ovulation. The aim of this cross-sectional study was to determine the relationship between circulating leptin concentrations, and anthropometric, metabolic and endocrine variables as well as to examine a possible role of leptin in ovarian dysfunction associated with PCOS.
DESIGN: Prospective observational study.
METHODS: Seventy-one subjects with PCOS and 23 body mass index (BMI)-matched control subjects were recruited from infertility clinics. The association between serum leptin concentrations and the above variables was measured outwith the luteal phase. A subgroup of 24 PCOS subjects underwent more frequent blood sampling to monitor follicular growth and ovulation. The association between variables was measured by univariate, multivariate and partial correlation analyses.
RESULTS: Serum leptin concentrations were not different in subjects with PCOS and controls, and were strongly associated with BMI in both groups. Twelve patients ovulated during the study period. There was no significant difference in serum leptin concentrations between ovulatory and anovulatory subjects. The relationship between BMI and leptin was similar in both groups.
CONCLUSION: The results indicated that circulating leptin concentrations relate principally to total body fat in subjects with PCOS and controls, and that this is not associated with the facility for follicular development and ovulation in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517009     DOI: 10.1530/eje.0.1450289

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

Review 1.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

2.  Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.

Authors:  L J Moran; C Meyer; S K Hutchison; S Zoungas; H J Teede
Journal:  J Endocrinol Invest       Date:  2009-10-15       Impact factor: 4.256

3.  Prediction of metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Fırat Ersan; Esra Arslan; Aytül Çorbacıoğlu Esmer; Serdar Aydın; Asuman Gedikbaşı; Ali Gedikbaşı; Ismet Alkış; Cemal Ark
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

4.  Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.

Authors:  A Fusco; A Bianchi; A Mancini; D Milardi; A Giampietro; V Cimino; T Porcelli; D Romualdi; M Guido; A Lanzone; A Pontecorvi; L De Marinis
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 5.  Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women.

Authors:  Dinka Pavicic Baldani; Lana Skrgatic; Roya Ougouag
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

6.  Adiponectin to Leptin Ratio and its Association with Insulin Resistance in Women with Polycystic Ovarian Syndrome.

Authors:  Pragya Mishra; Pratima Mittal; Anita Rani; Rekha Bharti; Varsha Agarwal; Jyotsna Suri
Journal:  Indian J Endocrinol Metab       Date:  2022-08-04

Review 7.  Leptin signaling and circuits in puberty and fertility.

Authors:  Carol F Elias; Darshana Purohit
Journal:  Cell Mol Life Sci       Date:  2012-08-02       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.